Visualization of plasma and tissue binding using dose fractions parameter
- PMID: 25315512
- DOI: 10.1002/ddr.21226
Visualization of plasma and tissue binding using dose fractions parameter
Abstract
A novel concept of dose fractions, based on the distribution of total bioavailable dose between the six combinations of location and binding state in Øie-Tozer's model is suggested as a way to visualize the distribution pharmacokinetics of a drug. The concept of dose fractions provides a sharper terminology in discussions of drug distribution allowing for a more precise description of the state and location of a drug within a system. In medicinal chemistry literature, the free fraction of a drug in plasma is a commonly discussed factor affecting the exposure to free drug while tissue binding is less well addressed. The free dose fraction, defined as the fraction of the bioavailable dose existing in free form, is suggested as a potentially valuable term for such discussions. Presently, drugs with high (>95%) plasma protein binding are viewed with skepticism, the rational behind which is questioned. The plasma protein bound dose fraction defined as the fraction of the total available dose, which is bound to plasma proteins, is suggested as a measure of the risk for problems related to fluctuations in free drug exposure due to variations in the concentration of drug binding plasma protein.
Keywords: disposition; distribution; dose fraction; in vitro/in vivo correlations; protein binding.
© 2014 Wiley Periodicals, Inc.
Similar articles
-
The impact of the concentration of drug binding plasma proteins on drug distribution according to Øie-Tozer's model.Xenobiotica. 2016;46(4):307-14. doi: 10.3109/00498254.2015.1074764. Epub 2015 Aug 10. Xenobiotica. 2016. PMID: 26259025
-
The usefulness of Øie-Tozer's model in deriving pharmacokinetic changes in response to changes in the concentration of drug-binding plasma protein.Xenobiotica. 2016 Jul;46(7):659-663. doi: 10.3109/00498254.2015.1104562. Epub 2015 Nov 2. Xenobiotica. 2016. PMID: 30179078
-
Investigation of the prerequisites for the optimization of specific plasma protein binding as a strategy for the reduction of first-pass hepatic metabolism.Xenobiotica. 2015 Apr;45(4):286-301. doi: 10.3109/00498254.2014.978413. Epub 2014 Nov 3. Xenobiotica. 2015. PMID: 25364858
-
Rational use of plasma protein and tissue binding data in drug design.J Med Chem. 2014 Oct 23;57(20):8238-48. doi: 10.1021/jm5007935. Epub 2014 Aug 6. J Med Chem. 2014. PMID: 25099658 Review.
-
Kinetic determinants of hepatic clearance: plasma protein binding and hepatic uptake.Xenobiotica. 2007 Oct-Nov;37(10-11):1110-34. doi: 10.1080/00498250701658296. Xenobiotica. 2007. PMID: 17968739 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources